Dr. Daniel Ermann joined the Huntsman Cancer Institute at the University of Utah for fellowship in Hematology/Oncology in 2020. His focus is in treating patients with various forms of lymphoma including diffuse large b-cell lymphoma and chronic lymphocytic leukemia. He completed his internal medicine residency at Creighton University in Omaha, Nebraska and, while there was nominated a Chief Resident of Internal Medicine. Additionally, Dr. Ermann has been the recipient of several academic awards including the ASH abstract achievement award and the ASCO merit award. His research focuses on ways to improve survival outcomes for patients with lymphoma through prospective and retrospective studies.